|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.350 USD | +0.38% |
|
+8.74% | +369.30% |
| 07-20 | Guggenheim Initiates AN2 Therapeutics at Buy With $9 Price Target | MT |
| 06-29 | AN2 Therapeutics, Inc.(NasdaqGS:ANTX) added to Russell 2000 Index | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 5.46 | 5.46 | 10.38 |
| Spread/Res. | -2.01% | -2.01% | -48.46% |
| Spread/Supp. | +24.42% | +116.60% | +130.60% |
| Support | 4.3 | 2.47 | 2.32 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ANTX Stock
- Charts AN2 Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
